ENVESTNET ASSET MANAGEMENT INC

Position in IMCR — Immunocore Holdings plc

CIK 1407543 Berwyn, PA

Position in IMCR

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$1,713,273

-$202,371 QoQ

Shares Held

56,825

+3.0% QoQ

Ownership

0.112%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ENVESTNET ASSET MANAGEMENT INC holds $767,426,760 across 109 Biotechnology names. IMCR ranks #42 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	503,564	$224,861,468
2	REGN	Regeneron Pharmaceuticals, Inc.	109,152	$84,335,201
3	ALNY	Alnylam Pharmaceuticals, Inc.	171,797	$56,842,473
4	INSM	INSMED Inc	299,925	$49,043,736
5	ARGX	Argenx SE	61,418	$44,850,494
6	RPRX	Royalty Pharma plc	495,892	$23,787,939
7	GMAB	Genmab A/S	862,301	$23,135,535
8	ROIV	Roivant Sciences Ltd.	678,518	$18,794,948

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,713,273	56,825	+3.0%	Shares	Sole	2026-05-04
2025-12-31	$1,915,644	55,190	-8.7%	Shares	Sole	2026-02-10
2025-09-30	$2,195,603	60,435	-4.5%	Shares	Sole	2025-11-05
2025-06-30	$1,985,946	63,287	-5.9%	Shares	Sole	2025-08-01
2025-03-31	$1,995,574	67,259	+1.1%	Shares	Sole	2025-04-29
2024-12-31	$1,962,458	66,524	-8.8%	Shares	Sole	2025-02-13
2024-09-30	$2,271,867	72,980	+3.4%	Shares	Sole	2024-11-07
2024-06-30	$2,391,651	70,571	+0.9%	Shares	Sole	2024-08-08
2024-03-31	$4,547,725	69,965	+2.0%	Shares	Sole	2024-05-13
2023-12-31	$4,684,975	68,574	+26.4%	Shares	Sole	2024-02-13
2023-09-30	$2,816,561	54,269	+195.1%	Shares	Sole	2023-11-13
2023-06-30	$1,102,844	18,393	+266.2%	Shares	Sole	2023-08-04
2023-03-31	$248,287	5,022	-2.0%	Shares	Sole	2023-05-11
2022-12-31	$292,483	5,125	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.